Davis D L, Bradlow H L, Wolff M, Woodruff T, Hoel D G, Anton-Culver H
Office of the Assistant Secretary for Health, Department of Health and Human Services, Washington, DC 20201.
Environ Health Perspect. 1993 Oct;101(5):372-7. doi: 10.1289/ehp.93101372.
Changes in documented risk factors for breast cancer and rates of screening cannot completely explain recent increases in incidence or mortality. Established risk factors for breast cancer, including genetics, account for at best 30% of cases. Most of these risk factors can be linked to total lifetime exposure to bioavailable estrogens. Experimental evidence reveals that compounds such as some chlorinated organics, polycyclic aromatic hydrocarbons (PAHs), triazine herbicides, and pharmaceuticals affect estrogen production and metabolism and thus function as xenoestrogens. Many of these xenoestrogenic compounds also experimentally induce mammary carcinogenesis. Recent epidemiologic studies have found that breast fat and serum lipids of women with breast cancer contain significantly elevated levels of some chlorinated organics compared with noncancer controls. As the proportion of inherited breast cancer in the population is small, most breast cancers are due to acquired mutations. Thus, the induction of breast cancer in the majority of cases stems from interactions between host factors, including genetics and environmental carcinogens. We hypothesize that substances such as xenoestrogens increase the risk of breast cancer by mechanisms which include interaction with breast-cancer susceptibility genes. A series of major epidemiologic studies need to be developed to evaluate this hypothesis, including studies of estrogen metabolism, the role of specific xenoestrogenic substances in breast cancer, and relevant genetic-environmental interactions. In addition, experimental studies are needed to evaluate biologic markers of suspect xenoestrogens and biologic markers of host susceptibility and identify pathways of estrogenicity that affect the development of breast cancer. If xenoestrogens do play a role in breast cancer, reductions in exposure will provide an opportunity for primary prevention of this growing disease.(ABSTRACT TRUNCATED AT 250 WORDS)
已记录的乳腺癌风险因素变化及筛查率无法完全解释近期发病率或死亡率的上升。包括遗传因素在内的既定乳腺癌风险因素最多只能解释30%的病例。这些风险因素大多可与一生中生物可利用雌激素的总暴露量相关联。实验证据表明,某些有机氯化合物、多环芳烃(PAHs)、三嗪类除草剂和药物等化合物会影响雌激素的产生和代谢,从而起到外源性雌激素的作用。许多这类外源性雌激素化合物在实验中也会诱发乳腺癌。最近的流行病学研究发现,与非癌症对照相比,乳腺癌女性的乳腺脂肪和血清脂质中某些有机氯化合物的含量显著升高。由于人群中遗传性乳腺癌的比例较小,大多数乳腺癌是由后天突变引起的。因此,大多数情况下乳腺癌的诱发源于宿主因素(包括遗传因素和环境致癌物)之间的相互作用。我们假设,外源性雌激素等物质通过与乳腺癌易感基因相互作用等机制增加乳腺癌风险。需要开展一系列主要的流行病学研究来评估这一假设,包括雌激素代谢研究、特定外源性雌激素物质在乳腺癌中的作用研究以及相关的基因-环境相互作用研究。此外,还需要进行实验研究,以评估可疑外源性雌激素的生物标志物和宿主易感性的生物标志物,并确定影响乳腺癌发展的雌激素作用途径。如果外源性雌激素确实在乳腺癌中起作用,减少接触将为预防这种日益增多的疾病提供一级预防的机会。(摘要截选至250词)